Head-To-Head Contrast: P3 Health Partners (NASDAQ:PIII) vs. Agilon Health (NYSE:AGL)

Agilon Health (NYSE:AGL) and P3 Health Partners (NASDAQ:PIII) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk.

Risk and Volatility

Agilon Health has a beta of 3.02, suggesting that its share price is 202% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500.

Insider and Institutional Ownership

7.7% of P3 Health Partners shares are held by institutional investors. 2.5% of Agilon Health shares are held by insiders. Comparatively, 10.9% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Agilon Health and P3 Health Partners”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93 billion	0.25	-$391.35 million	($14.27)	-6.24
P3 Health Partners	$1.46 billion	0.04	-$147.95 million	($33.00)	-0.23

P3 Health Partners has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Agilon Health and P3 Health Partners’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
P3 Health Partners	-6.55%	N/A	-16.40%

Analyst Recommendations

This is a summary of current ratings and target prices for Agilon Health and P3 Health Partners, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2	7	6	0	2.27
P3 Health Partners	1	2	1	0	2.00

Agilon Health currently has a consensus target price of $102.25, suggesting a potential upside of 14.88%. P3 Health Partners has a consensus target price of $17.00, suggesting a potential upside of 123.39%. Given P3 Health Partners’ higher possible upside, analysts clearly believe P3 Health Partners is more favorable than Agilon Health.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

About P3 Health Partners

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.